TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis
Increased inflammatory cytokines [such as tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)] are observed in COVID-19 patients, especially in the severe group. The phenomenon of a cytokine storm may be the central inducer of apoptosis of alveolar epithelial cells, which leads to rapid prog...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-05-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466620926800 |
id |
doaj-ecf43089a2df49f0a45f4efb707a5d47 |
---|---|
record_format |
Article |
spelling |
doaj-ecf43089a2df49f0a45f4efb707a5d472020-11-25T02:42:13ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662020-05-011410.1177/1753466620926800TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysisXue-Yan ChenBing-Xi YanXiao-Yong ManIncreased inflammatory cytokines [such as tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)] are observed in COVID-19 patients, especially in the severe group. The phenomenon of a cytokine storm may be the central inducer of apoptosis of alveolar epithelial cells, which leads to rapid progression in severe group patients. Given the similarities of clinical features and pathogenesis between toxic epidermal necrolysis (TEN) and COVID-19, we hypothesize that the application of etanercept, an inhibitor of TNFα, could attenuate disease progression in severe group COVID-19 patients by suppressing systemic auto-inflammatory responses. The reviews of this paper are available via the supplemental material section.https://doi.org/10.1177/1753466620926800 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xue-Yan Chen Bing-Xi Yan Xiao-Yong Man |
spellingShingle |
Xue-Yan Chen Bing-Xi Yan Xiao-Yong Man TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis Therapeutic Advances in Respiratory Disease |
author_facet |
Xue-Yan Chen Bing-Xi Yan Xiao-Yong Man |
author_sort |
Xue-Yan Chen |
title |
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
title_short |
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
title_full |
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
title_fullStr |
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
title_full_unstemmed |
TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis |
title_sort |
tnfα inhibitor may be effective for severe covid-19: learning from toxic epidermal necrolysis |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Respiratory Disease |
issn |
1753-4666 |
publishDate |
2020-05-01 |
description |
Increased inflammatory cytokines [such as tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)] are observed in COVID-19 patients, especially in the severe group. The phenomenon of a cytokine storm may be the central inducer of apoptosis of alveolar epithelial cells, which leads to rapid progression in severe group patients. Given the similarities of clinical features and pathogenesis between toxic epidermal necrolysis (TEN) and COVID-19, we hypothesize that the application of etanercept, an inhibitor of TNFα, could attenuate disease progression in severe group COVID-19 patients by suppressing systemic auto-inflammatory responses. The reviews of this paper are available via the supplemental material section. |
url |
https://doi.org/10.1177/1753466620926800 |
work_keys_str_mv |
AT xueyanchen tnfainhibitormaybeeffectiveforseverecovid19learningfromtoxicepidermalnecrolysis AT bingxiyan tnfainhibitormaybeeffectiveforseverecovid19learningfromtoxicepidermalnecrolysis AT xiaoyongman tnfainhibitormaybeeffectiveforseverecovid19learningfromtoxicepidermalnecrolysis |
_version_ |
1724774578399477760 |